Develops precision therapeutics for central nervous system disorders (psychiatric, neurologic, and addiction) using a transdiagnostic, biomarker-driven approach that targets core disease mechanisms. Uses novel drug formulations and delivery strategies plus partner-enabled development to maximize therapeutic efficacy and development efficiency.